Viewing Study NCT00064350


Ignite Creation Date: 2025-12-24 @ 4:57 PM
Ignite Modification Date: 2026-03-20 @ 6:47 AM
Study NCT ID: NCT00064350
Status: COMPLETED
Last Update Posted: 2023-06-29
First Post: 2003-07-08
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer
Sponsor: Eastern Cooperative Oncology Group
Organization:

Organization Data

Organization:
Class: NETWORK
Study ID: CDR0000315383
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View